These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 14558327)
1. [Pure red cell aplasia and antibodies against erythropoietin. Doubts still remain]. Peces R Nefrologia; 2003; 23(4):295-6, 297. PubMed ID: 14558327 [No Abstract] [Full Text] [Related]
2. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C. Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778 [TBL] [Abstract][Full Text] [Related]
3. [Pure red blood cell aplasia associated with neutralizing antibodies against erythropoietin induced by epoetin alfa:a new form of acquired erythroblastopenia in auremic patients]. Cases A; Esforzado N; Mas M; Ricart MJ; Cruzado JM Nefrologia; 2003; 23(3):266-70. PubMed ID: 12891943 [TBL] [Abstract][Full Text] [Related]
4. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another. Macdougall IC Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076 [TBL] [Abstract][Full Text] [Related]
11. Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge. Smalling R; Foote M; Molineux G; Swanson SJ; Elliott S Biotechnol Annu Rev; 2004; 10():237-50. PubMed ID: 15504708 [TBL] [Abstract][Full Text] [Related]
12. Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done? Macdougall IC; Roche A; Rossert J; Casadevall N; Francois P; Kemeny DM Nephrol Dial Transplant; 2004 Nov; 19(11):2901-5. PubMed ID: 15496566 [No Abstract] [Full Text] [Related]
13. Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation. Vartia A; Asola MR; Tertti R; Kunelius P; Metsärinne KP Nephrol Dial Transplant; 2004 May; 19(5):1313-6. PubMed ID: 15102972 [No Abstract] [Full Text] [Related]
14. Relationship between biopharmaceutical immunogenicity of epoetin alfa and pure red cell aplasia. Schellekens H Curr Med Res Opin; 2003; 19(5):433-4. PubMed ID: 13678481 [No Abstract] [Full Text] [Related]
15. Pure red-cell aplasia secondary to antierythropoietin antibodies. Guest SS; Levitt L N Engl J Med; 2003 Dec; 349(26):2572-3. PubMed ID: 14695426 [No Abstract] [Full Text] [Related]
16. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia. Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies. Ferbas J; Thomas J; Hodgson J; Gaur A; Casadevall N; Swanson SJ Clin Vaccine Immunol; 2007 Sep; 14(9):1165-72. PubMed ID: 17634512 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of erythropoietin-associated pure red cell aplasia. Carson KR; Evens AM; Bennett CL; Luminari S Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921 [TBL] [Abstract][Full Text] [Related]
19. Pure red cell aplasia induced by erythropoiesis-stimulating agents. Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785 [TBL] [Abstract][Full Text] [Related]
20. Response to cyclosporine A in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies. Fraer M; Campbell A; Sawaya BP Semin Dial; 2006; 19(3):251-4. PubMed ID: 16689978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]